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Abstract
Background: Although animal and human studies have demonstrated interactions between dietary choline and
fetal alcohol spectrum disorders, dietary choline deficiency in pregnancy is common in the US and worldwide. We
sought to develop and validate a quantitative food frequency questionnaire (QFFQ) to estimate usual daily choline
intake in pregnant mothers.
Methods: A panel of nutrition experts developed a Choline-QFFQ food item list, including sources with high
choline content and the most commonly consumed choline-containing foods in the target population. A data base
for choline content of each item was compiled. For reliability and validity testing in a prospective longitudinal
cohort, 123 heavy drinking Cape Coloured pregnant women and 83 abstaining/light-drinking controls were
recruited at their first antenatal clinic visit. At 3 prenatal study visits, each gravida was interviewed about alcohol,
smoking, and drug use, and administered a 24-hour recall interview and the Choline-QFFQ.
Results: Across all visits and assessments, > 78% of heavy drinkers and controls reported choline intake below the
Dietary Reference Intakes adequate intake level (450 mg/day). Women reported a decrease in choline intake over
time on the QFFQ. Reliability of the QFFQ across visits was good-to-acceptable for 2 of 4 group-level tests and 4 of
5 individual-level tests for both drinkers and controls. When compared with 24-hr recall data, validity of the QFFQ
was good-to-acceptable for 3 of 4 individual-level tests and 3 of 5 group-level tests. For controls, validity was
good-to-acceptable for all 4 individual-level tests and all 5 group-level tests.
Conclusions: To our knowledge, this is the first quantitative choline food frequency screening questionnaire to be
developed and validated for use with both heavy and non-drinking pregnant women and the first to be used in
the Cape Coloured community in South Africa. Given the high prevalence of inadequate choline intake and the
growing evidence that maternal choline supplementation can mitigate some of the adverse effects of prenatal
alcohol exposure, this tool may be useful for both research and future clinical outreach programs.
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Background
Fetal alcohol spectrum disorders (FASD) comprise a con-
tinuum of alcohol-related neurodevelopmental disorders
ranging from the most severely affected children with fetal
alcohol syndrome (FAS) to nonsyndromal children who
also exhibit neurocognitive and/or behavioral deficits but
may lack the facial features or growth deficits seen with
FAS [1, 2]. Worldwide, a significant number of women
drink heavily during pregnancy despite public health
advisories and psychosocial interventions [3–5]. In the
Western Cape Province of South Africa, where rates of
heavy drinking during pregnancy are endemically high
among women from the Cape Coloured (mixed ancestry)
community [6–8], the prevalence of FAS is as high as 80
per 1000 [9].
A growing body of studies in FASD animal models has
demonstrated that optimal maternal choline status can
mitigate some of the teratogenic effects of alcohol [7,
10–16]. Thomas and colleagues have shown protective ef-
fects of pre- and postnatal choline supplementation on
hippocampal development and related neurobehavioral
outcomes in rats [10, 11], including reversal of
alcohol-related deficits in eyeblink conditioning, which we
have also shown to be profoundly affected in children pre-
natally exposed to alcohol [7, 12, 13]. We have recently
extended these findings to humans in an exploratory ran-
domized, double-blind, controlled trial, which demon-
strated that high-dose choline supplementation initiated
early in pregnancy can mitigate adverse effects of heavy
drinking on infant eyeblink conditioning, cognition, and
post-natal growth [14, 15].
Choline is an essential nutrient that is a constituent of
the neurotransmitter acetylcholine and a precursor to
phosphatidylcholine and sphingomyelin, which are major
components of cell membranes and play an important
role in cell membrane integrity, trans-membrane signal-
ing, and triglyceride turnover from the liver and blood
[16]. In addition, it serves as a methyl-group donor
needed for homocysteine metabolism and DNA methyla-
tion, a critical mechanism in epigenetic processes that has
been implicated in alcohol teratogenesis. Despite the fact
that choline can be produced endogenously, it is classified
as an essential nutrient [17, 18], and dietary intake, princi-
pally from eggs, liver, wheat germ, and milk, is imperative
to meet physiological needs. The demand for choline is
especially high during pregnancy, when it is actively
transported to the fetus against a concentration gradient
[19] and depletes maternal stores [20, 21]. In a recent
randomized, double-blind, controlled trial comparing two
3rd-trimester dietary regimens – 480 mg choline/day (just
above the adequate intake level of 450 mg/day [19]) vs.
930 mg/day (just over twice adequate intake level), the
higher choline intake arm was associated with faster infant
processing speed through age 13 mo [22].
We have recently demonstrated that, although the diet
and body composition of heavy drinking pregnant
women is similar to that of abstaining/light-drinking
pregnant women in socio-economically disadvantaged
areas in Cape Town, South Africa, in repeated 24-hr
dietary recall interviews, almost 90% of the women
reported inadequate intake of choline [23]. High rates of
inadequate choline intake during pregnancy have also
been reported in the U.S. (90%) [24, 25], Canada (77%)
[26], and New Zealand (84%) [27]. These studies
emphasize the importance of assessment of dietary
choline intake in groups at risk for inadequate intake,
such as pregnant women, to inform dietary choline in-
terventions, as well as the use of choline supplements.
The use of repeated 24-hour recall interviews to assess
usual daily intake of micronutrients has been validated
in the U.S. and in resource-poor settings but is both
labor and time-intensive [28]. One alternative is to use a
dietary intake assessment method that focuses specific-
ally on quantification of choline content using a quanti-
tative nutrient-indicated food frequency questionnaire
(QFFQ). This methodology is increasingly applied in as-
sessment of usual intake of single nutrients (e.g., vitamin
D [29], iron [30], and vitamin K [31].
We developed a quantitative choline food frequency
questionnaire (Choline-QFFQ) to estimate usual dietary
choline intake (mg/day) by participants in our Cape Town
randomized clinical trial conducted to assess feasibility
and efficacy of a maternal choline supplementation inter-
vention conducted with heavy drinking women during
pregnancy [14, 15]. The current study combines data from
this trial and from our larger prospective longitudinal
cohort on the effects of prenatal alcohol exposure on
development that included both heavy drinking and
abstaining/light-drinking pregnant women from the same
community as the women in the trial [8, 32]. Our aims
were (1) to develop a Choline-QFFQ that can be used
to estimate usual daily intake of dietary choline and (2) to
test its reliability and validity in both heavy drinkers and
abstainers/light-drinkers.
Methods
Development of the Choline-QFFQ
The Choline-QFFQ food item list was developed by a
panel of three nutrition experts in the Division of
Human Nutrition, University of Cape Town, including
M.S, S.B, and B.N., in which food sources with high cho-
line content, as well as the most commonly consumed
foods in the target population were included. The food
sources list was derived from Nel and Steyn [33] and
multiple unpublished field studies completed by
post-graduate students in dietetics in Cape Town, South
Africa. In addition to high choline-content foods,
commonly consumed food sources with moderate or
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low-choline content were included in the final food list,
as frequent consumption of such foods may also make a
considerable contribution to choline intake. Lewis et al.
[26] demonstrated that vegetables, baked products and
fruits that are moderate to low sources of choline pro-
vided 8.5%, 7.7% and 6.6%, respectively, of total choline
intake versus 12.2% provided by eggs and 11.1% by meat,
which contain high levels of choline. The final food list
was comprised of 10 groups, including beef (organ,
mince, patty, chops and braised beef ), lamb (chops and
stew), chicken (fried or roasted in different cuts, giblets
and liver), processed meats (salami, ham, polony, viennas
and frankfurters), fish (canned sardines and canned
pilchards), eggs (boiled or fried), legumes (baked beans,
lentils, sugar beans, soy beans), vegetables (cauliflower,
broccoli, corn/mealies, peas, mixed vegetables, spinach,
gem squash, pumpkin, potatoes – fried or mashed with
added milk), fruit (banana), dairy (milk drink, milk
added to cereal or in tea/coffee and yoghurt) and other
items (beer, chocolate cake, tomato sauce/ketchup and
peanut butter). Participants were requested to report the
number of times a particular food item had been
consumed during the past week, either number of times
per day, if consumed daily, or otherwise number of times
in the past week.
The picture sort method was used for administration
of the Choline-QFFQ, whereby participants were asked
to sort picture cards of food items included in the food
list into two piles, those consumed during the past week
and those not consumed during the past week. Inter-
viewers, either a registered dietician or a research assist-
ant with extensive training in dietary interviewing by
M.S., then proceeded to quantify the frequency of intake
and typical portion size for items that had been con-
sumed during the past week. Portion size estimation was
conducted using pictures and portion size props (Fig. 1)
included in the Dietary Assessment and Education Kit
(DAEK) [34]. The Choline-QFFQ was pilot-tested with
24 women of child-bearing age from the same commu-
nity as the main cohort in this study. Ease of procedure,
face validity, and acceptability among subjects were
excellent.
Study Participants for Reliability and Validity Testing
This study included pregnant women from the Cape
Coloured (mixed ancestry) community who were re-
cruited to participate in the choline clinical trial [14, 15]
or the prospective longitudinal study [23] between Octo-
ber 2011 and December 2015. Women were recruited at
their first visit to one of three antenatal midwife obstet-
ric units that serve socioeconomically-disadvantaged
communities in Cape Town (see [15, 16, 27] for further
subject eligibility, recruitment, retention, and sample size
calculation details). Each mother was interviewed at
screening (M = 21.1 weeks gestation, SD = 6.1) regard-
ing her alcohol consumption both at time of conception
and recruitment and again at 4 and 12 weeks after
recruitment, by a research nurse using the timeline
follow-back interview (TLFB; [35]) adapted for use with
women in this community [7, 32]. Any woman averaging
at least 1.0 oz absolute alcohol (AA)/day (1 oz AA~2
standard drinks) or reporting binge drinking (≥2.0 oz
AA/drinking occasion) was invited to participate in the
study. Women initiating antenatal care who drank only
minimally and did not binge drink were invited to par-
ticipate as abstainers/light drinkers. Exclusion criteria in-
cluded age <18 years, HIV infection, and pharmacologic
treatment for medical conditions, including diabetes,
hypertension, epilepsy, or cardiac problems. All women
who reported drinking during pregnancy were advised to
stop or reduce their intake, and women were offered a
referral for substance abuse treatment programs.
Consent and interviews were conducted in Afrikaans or
English, depending on the mother’s preference.
Reliability and validity testing of the Choline-QFFQ
Study visits occurred at recruitment and again 4 and 12
weeks later. Both the test method (Choline-QFFQ) and
reference method (24-hr recall) were administered at
each visit, with the reference method given first. The
reliability of the Choline-QFFQ was tested by comparing
the results of three administrations of the questionnaire.
The validity of the Choline-QFFQ was tested using a
dietary reference method (three repeated 24-hour re-
calls). 24-hr dietary recall interviews were administered
using the multiple-pass method [28] and pictures and
portion size props provided by the DAEK (Steyn &
Senekal 2004). Hand-written dietary records were
reviewed by a U.S. registered dietician/research scientist
(L.B.) who entered these data into the FoodFinder3®
software program. The two interviewers and L.B. held
regular Skype® meetings to discuss the interviews, ques-
tions that arose, and any outliers found.
Since FoodFinder3® does not provide values for choline
content, a database was created to estimate the choline
content of foods consumed by the women in the study.
All foods reported by women in 24-hr dietary recall
interviews and any additional foods included in the
Choline-QFFQ (total = 382 foods) were matched to
preparation-specific food items in the USDA Database
for the Choline Content of Common Foods (Release 2
[36]). Choline content was calculated by linking the
nutrient database number used in the USDA choline
database with that used in the USDA National Nutrient
Database for Standard Reference. For 16 reported foods
that were not listed in the USDA choline database and
consisted of multiple food items, recipes were con-
structed and used to calculate choline content based on
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the quantity and content of individual ingredients. An
additional 21 foods not listed in the USDA choline
database were matched with nutritionally comparable
foods, chosen by M.S. and R.C. based on similar content,
energy, and appearance. One food, Maltabella (reported
in two 24-hr recall interviews), was not included, as no
appropriate substitution could be found. Total choline
content was calculated for each 24-hr recall interview
and each Choline-QFFQ. Values from the three 24-hr
recall interviews for a given woman were then averaged
to calculate usual daily intake, which was used as the
reference method value [32]. Inadequate dietary choline
intake was defined as average daily intake below the
Adequate Intake level (AI) per the Dietary Reference
Intake [19].
Statistical analyses
Statistical analyses were performed using SPSS v.23
software (IBM, Chicago, IL, USA). Reliability and validity
analyses were conducted separately for drinkers and ab-
stainers/light-drinkers. Reliability of the Choline-QFFQ
was assessed by comparing the daily dietary choline
intake values between visits 1 and 2; visits 2 and 3; and
visits 1 and 3, adapting the validity analyses and inter-
pretations suggested by Lombard et al. [37]. Validity was
assessed by comparing daily choline intake from the
reference method (average of the woman’s three 24-hr
recall interviews) with daily dietary intake from the
QFFQ at visit 1, the average of visits 1-2, and the average
of visits 1-3; the latter two comparisons were conducted
to evaluate whether validity is better with repeated ad-
ministration of the QFFQ. Group-level agreement was
examined using the Wilcoxon signed-rank test and by
examining the mean difference between intake values
from repeated QFFQ applications as a percentage of the
recall value. To assess potential bias, Spearman correl-
ation coefficients were calculated between the mean of
the intake values for the repeated QFFQ applications
and the mean difference of the two values (from
Bland-Altman analyses). As suggested by Kowalkowska
et al. [38], we also calculated the Bland Altman Index,
the percentage of subjects with values outside of the
limits of agreement (LOA; defined as mean ± 1.96 SD),
with < 5% being acceptable. Individual agreement was
Fig. 1 Pictures and portion size props used from the Dietary Assessment and Education Kit [34]
Carter et al. Nutrition Journal          (2018) 17:108 Page 4 of 13
examined by calculating the percentage of individuals
placed in the same tertile by each measure and the
percentage placed in opposite tertiles (i.e., lowest tertile
for one and highest tertile for the other) and by calculat-
ing a weighted kappa statistic. A kappa statistic was also
calculated to assess agreement on whether a woman
reported intake below the choline AI. Spearman correl-
ation was used to assess the strength of agreement
between visits at the individual level. Intraclass correla-
tions and within-subject coefficients of variation for [39]
dietary nutrient intakes were calculated using the





The majority of the mothers (89.8%) were 20-40 years of
age, and drinkers were 2 years older than abstainers/light--
drinkers on average (Table 1). Three-fourths (76.1%) of
the women had attended high school, but only 12.2%
completed high school. Drinkers had attended school
almost 1 year less than abstainers/light-drinkers. Average
daily energy intake was similar between drinkers and ab-
stainers/light-drinkers and was below the 2400 kcal/day
recommended during pregnancy. As we have previously
reported, the majority of the women received prenatal
iron/folic acid supplementation and reported good adher-
ence, taking the supplement on most days [23]. Almost
three-quarters (72.5%) had full-term pregnancies. Almost
all women (94.7%) completed at least two interviews, and
64.6% completed three interviews. Heavy drinkers and ab-
stainers/light-drinkers did not differ in number of visits.
As expected, alcohol use was heavy among drinkers, who
averaged 9.4 standard drinks per occasion on 2.4 days per
week around time of conception and 8.4 standard drinks
on 1.3 days per week across pregnancy. All but 8 controls
(9.6%) abstained from alcohol use: 4 reported drinking < 2
drinks per occasion (three of these reported 3 or fewer
occasions, one 1-2 occasions per week); 2 drank < 3 drinks
per occasion 1-2 times per month; and 2 reported a single
binge episode that occured following recruitment into the
study.
Dietary choline intake
A large majority of women in both the heavy drinking
and abstaining/light-drinking groups reported choline
intake below the AI (Table 2). Both heavy drinkers and
abstainers/light-drinkers in the cohort reported a lower
choline intake at each consecutive visit on both the
24-hr recall interviews and the QFFQs, but this decrease
over time was only statistically significant on the QFFQ.
We have previously reported that average daily choline
intake and the prevalence of inadequate intake were
similar between heavy drinkers and abstainers/light-drin-
kers [23].
Reliability of the Choline-QFFQ
When examining the group-level reliability of the
Choline-QFFQ among heavy drinkers between visits,
results for percentage difference pointed to good agree-
ment, while agreement reflected by the Wilcoxon signed
rank test was poor (Table 3). In Bland-Altman analyses,
5% or fewer of values fell outside of the limit of agree-
ment (LOA) when comparing visits 1 and 2 and visits 2
and 3, but just above the 5% cutoff when comparing
visits 1 and 3. Bias was evident in the Bland Altman
Spearman correlation analyses with a positive correlation
between the difference in reported intake between the
two visits and the mean choline intake value for the 2
visits. Results for individual-level tests showed that
percentage classified in the same tertiles and opposite
tertiles (agreement including chance) was good for all
comparisons with the exception of visit 1 vs. visit 3,
which was poor. Agreement excluding chance, as
reflected by the weighted kappa statistic, and strength of
agreement, reflected by the Spearman correlation
coefficient, was acceptable-to-good for all comparisons.
Results were almost identical among abstainers/light--
drinkers for group- and individual-level tests. Values for
the QFFQ within-subject coefficient of variation (.53)
and the ratio of within- to between-subject variance
(2.2) were similar to those for 24-hr recall interviews
(.58 and 2.1, respectively).
Validity of the Choline-QFFQ
Among drinkers, agreement was good-to-acceptable on
most group-level tests, with the exception of percentage
difference between QFFQ values at visit 1 and the mean
of the 24-hr recall interviews (reference method) and the
LOA index when averaging QFFQ values from visits 1-2
(Table 4). Individual-level tests among drinkers were good
for the Spearman correlation, acceptable for the weighted
kappa test, and poor for both tertile classification methods
(46.6% vs. ≥ 50% cutoff and 10.3% vs. ≤10% cutoff).
Among abstainers/light-drinkers, all group-level tests were
acceptable-to-good except for Bland-Altman Spearman
correlation when using only visit 1 QFFQ values, with a
weak, positive bias seen. At the individual-level, all tests
were acceptable-to-good except for same-tertile classifica-
tion when using the mean of visits 1-3, which was poor.
Discussion
In this prospective longitudinal cohort of heavy drinking
pregnant women and abstainers/light-drinkers, we devel-
oped and demonstrated reliability and validity of a QFFQ
that assesses average daily choline intake and requires
minimal time (~10-15 minutes) and resources (food
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identification cards and portion estimation props) to ad-
minister. To our knowledge, this is the first
Choline-QFFQ to be developed and validated for use with
pregnant women and the first to be used in the Cape
Coloured community in South Africa. While this choline
quantitative FFQ presented is specific to the Cape
Coloured population, the development and validation
steps we employed may be used to develop population-
specific choline quantitative screening FFQs in other pop-
ulations. Furthermore, the Choline-QFFQ performed well
in our study population, suggesting that a Choline-QFFQ
(and the development and validations steps we employed)
can be used even in populations in which education is
poor and/or socioeconomic status low. Despite extensive
prevention efforts and guidelines (ACOG, 2011) and 4 de-
cades of scientific research demonstrating teratogenic ef-
fects of prenatal alcohol exposure, women worldwide
continue to drink during pregnancy. FASD comprise the
most common preventable cause of neurodevelopmental
disabilities, with prevalence estimates of 1.1-5.0% in the
US and Western Europe [40, 41] and 13.6-20.9% in South
Africa [9]. Evidence from both animal [10, 11, 42, 43] and
human [14, 15] studies has demonstrated that high-dose
choline supplementation can mitigate many of the terato-
genic effects of alcohol. It is thus of concern that over 80%
of the both heavy drinkers and abstainers/light-drinkers in
this study reported choline intake below the AI in all as-
sessments, as has been reported in other populations such
as the U.S. [25], Canada [26], and New Zealand [27].
Given our reliability and validity findings, the QFFQ de-
veloped in this study may be used to screen alcohol-using
pregnant mothers in Cape Town to identify women who
may benefit from choline interventions, whether they be
dietary counseling or choline supplementation programs.
Given our finding that abstaining/light-drinking women in
this cohort had similarly high rates of dietary choline
inadequacy, this QFFQ may also be used to identify
non-drinking pregnant women at risk for choline
Table 1 Sample characteristics
Heavy drinkers Abstainers/light drinkers pa
N M SD n % N M SD n %
Maternal age at conception (yr) 122 27.7 5.7 83 25.5 4.8 .004
Gravidity (no.) 122 2.9 1.7 83 2.5 1.3 .109
Marital status (no. married) 122 34 27.6 83 34 41.0 .046
Education (yr school completed) 122 9.3 1.7 83 10.0 1.6 .005
Average daily energy intake (kilocalories/day) 122 2247.9 810.1 83 2343.0 857.7 .421
Received prenatal iron/folic acid supplementation 119 104 87.4 80 69 86.3 .814
Takes supplements most days (supplemented only) 104 90.4 65 93.2 .367
Number of visits 122 2.6 0.7 83 2.5 0.7 .110
Weeks gestation
Initiation of antenatal care 122 17.3 5.9 83 18.7 6.0 .111
Visit 1 122 22.9 5.8 83 25.5 5.0 .001
Visit 2 116 27.0 5.6 78 29.9 5.0 <.001
Visit 3 78 32.5 4.0 46 34.0 3.9 .050
Delivery 122 38.8 2.1 83 39.0 2.2 .626
Alcohol and drug use
AA/day (oz) 122 0.9 1.2 83 0.0 0.0 <.001
AA/drinking day (oz) 122 4.2 2.4 83 0.2 0.5 <.001
Drinking days/wk (days) 122 1.3 1.1 83 0.0 0.1 <.001
No. reporting cigarette smoking 122 106 86.2 83 57 68.7 .002
Cigarettes/day (smokers only) 6.8 4.1 6.1 5.9 .435
No. reporting marijuana use 122 29 23.6 83 8 9.6 .011
Marijuana use (users only; days/mo) 9.7 9.4 4.0 4.7 .026
No. reporting methamphetamine use 122 12 9.8 83 15 18.1 .083
Methamphetamine use (users only; days/mo) 4.5 5.4 8.8 8.0 .119
AA = absolute alcohol; 1 oz AA ≈ 2 standard drinks
aFrom χ2 for categorical variables and t-tests for all continuous variables except for weight, BMI, triceps and biceps skinfolds, and MUAC, for which values from
repeated measures regression models are presented; weight, BMI and MUAC models include control for weeks gestation at time of measurement
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deficiency, which poses its own potential harms to the
mother and developing fetus, including neural tube and
craniofacial defects, as well as possible effects on neurocog-
nitive development [18, 24, 44, 45].
The steps of development and validation we employed
can be used to develop population-specific choline quanti-
tative screening FFQs in other populations. Development
and validation of a nutrient-specific screening QFFQ in-
volved several steps, including 1) development of the local
food list; 2) determining the most appropriate recall
period, frequency options and portion size estimation
method(s), based on the aim of the dietary intake assess-
ment, the target population, and time available for the
administration; 3) identifying an appropriate reference
method; and 4) identification of interpretable statistical
tests for examining the reliability and validity of the newly
developed QFFQ. The food list for our Choline-QFFQ
was developed based on the integration of the best known
dietary sources of choline and knowledge of commonly
consumed foods in the Cape Coloured community in
Cape Town by a panel of nutrition researchers with ex-
pertise on the dietary patterns of the target population.
The recall period was set at the previous week based on
recommendations by Willett [28]. Portion size estimation
was based on portions used in the FoodFinder program,
which was developed for use in this population, and
modified based on pilot interviews with women from this
community. Administration of the Choline-QFFQ using
the picture sort method proved to be simple and quick
(~10-15 minutes), which is ideal for implementation as a
screening procedure in a community healthcare setting.
The dietary reference method used was three 24-hour
Table 2 Daily choline intake values by 24-hr recall interviews and semi-quantitative food frequency questionnaire (QFFQ)
Intake below AI Average daily intake (mg)
n (%) Mean (SD) Median (IQR)
Heavy drinkers
24-hr recalla
Visit 1 (n = 122) 95 (77.9) 338.6 (257.1) 275.4 (156.7 – 410.5)
Visit 2 (n = 116) 96 (82.8) 310.8 (221.0) 257.6 (176.1 – 359.4)
Visit 3 (n = 86) 73 (84.9) 279.8 (185.8) 229.1 (141.3 – 370.0)
Visits 1-2 (mean; n = 116) 94 (81.0) 327.5 (200.0) 274.7 (194.6 – 409.5)
Visits 1-3 (mean; n = 86) 73 (84.9) 304.6 (147.6) 273.9 (195.7 – 379.3)
QFFQb
Visit 1 (n = 121) 97 (80.2) 340.4 (205.1) 293.0 (208.2 – 436.0)
Visit 2 (n = 112) 100 (89.3) 286.0 (160.5) 267.9 (176.7 – 352.0)
Visit 3 (n = 78) 67 (85.9) 259.1 (160.5) 259.1 (175.9 – 337.4)
Visits 1-2 (mean; n = 112) 97 (86.6) 312.1 (152.1) 301.8 (203.3 – 386.9)
Visits 1-3 (mean; n = 78) 70 (89.7) 322.8 (180.5) 288.8 (186.3 – 410.5)
Abstainers/light drinkers
24-hr recalla
Visit 1 (n = 83) 70 (84.3) 336.8 (255.9) 279.7 (182.5 – 406.1)
Visit 2 (n = 78) 61 (78.2) 305.7 (179.7) 267.1 (151.8 – 416.7)
Visit 3 (n = 47) 39 (83.0) 285.9 (175.7) 232.2 (164.6 – 348.3)
Visits 1-2 (mean; n = 78) 66 (84.6) 318.1 (178.1) 282.6 (186.8 – 386.4)
Visits 1-3 (mean; n =47 ) 39 (83.0) 303.1 (171.1) 247.6 (196.5 – 364.1)
QFFQb
Visit 1 (n = 83) 68 (81.9) 316.4 (215.1) 277.8 (166.5 – 378.5)
Visit 2 (n = 72) 62 (86.1) 275.3 (162.2) 279.0 (149.0 – 356.7)
Visit 3 (n = 42) 39 (92.9) 199.6 (113.5) 164.3 (125.1 – 211.9)
Visits 1-2 (mean; n = 72) 64 (77.1) 304.9 (178.0) 279.1 (175.7 – 402.9)
Visits 1-3 (mean; n = 42) 37 (88.1) 290.7 (169.6) 266.5 (161.6 – 371.2)
AI = adequate intake (450 mg choline/day)
aPaired t-test comparing values between visits: Drinkers: p = .191 for visits 1-2, .607 for visits 2-3, and .055 for visits 1-3; Abstainers/light-drinkers: p = .380 for visits
1-2, .702 for visits 2-3, and .318 for visits 1-3.
bPaired t-test comparing values between visits: Drinkers: p = .006 for visits 1-2, .921 for visits 2-3, and .019 for visits 1-3; Abstainers/light-drinkers: p = .224 for visits
1-2, .001 for visits 2-3, and .009 for visits 1-3.
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recall interviews, the method most strongly recommended
for validation of food frequency questionnaires [32],
especially in communities where literacy and educa-
tion issues may preclude the use of food diaries, such
as this socioeconomically disadvantaged community in
Cape Town.
We used the statistical tests and interpretations
recommended by Lombard et al. [37] to assess different
features of reliability and validity. Lombard recommends
three group-level comparison tests (comparison of
means using the Wilcoxon signed rank test, percentage
difference, and Bland Altman Spearman test for bias)
and four individual-level tests (Spearman correlation
coefficient, same- and opposite-tertile classification, and
the weighted kappa statistic for tertile classification). We
added a fourth group-level test, the Bland Altman limit
of agreement index (as recommended by Kowalkowska
et al. [38]), and a fifth individual-level test, a kappa stat-
istic examining the classification agreement for whether
a woman reported intake below the choline AI, to pro-
vide a measure of clinical relevance. Group level tests
are most relevant for research studies, where errors for a
single woman are less important as long as group-level
associations are acceptable-to-good, and individual-level
tests are most relevant for clinical practice, in which a
woman’s reported values will guide targeted recommen-
dations and/or interventions. The majority of the five
individual level statistical tests indicated acceptable to
good reliability of the QFFQ for all comparisons
conducted for both heavy drinkers and abstainers/light--
drinkers, except for comparisons of visits 1 and 3 among
drinkers, suggesting that reliability may decline over
time. At the group level, reliability was good-to-accept-
able for 2 of 4 tests, namely percentage difference in re-
ported values between visits (≤ 20% = acceptable) and
the Bland Altman limit of agreement index, a measure
of how many outliers are present. Reliability was poor
for the Wilcoxon signed rank test, a measure of how
similarly ranked women are between visits, and the
Bland Altman test for bias, which demonstrated a
greater difference between reported intake between visits
if the reported intake was higher. When examining the
validity of the Choline-QFFQ compared with the mean
of three 24-hour recalls, all group-level tests were
acceptable-to-good, as were all individual level test
results, except for classification into tertiles for the
alcohol users for all comparisons conducted. Of note,
the weighted kappa statistic for tertile classification was
acceptable across almost all comparisons. The weighted
kappa assesses agreement excluding chance and thus
may provide a more accurate measure of agreement than
the raw tertile agreement % measures.
Reliability and validity are measured separately, but
results of the tests should be interpreted in light of each
other. Although the QFFQ demonstrated both reliability
and validity, tests of validity were more consistently
acceptable-to-good than tests of reliability, particularly
at the group level, as reflected in the Wilcoxon and
Bland Altman bias tests, and the individual-level, when
examining agreement as to whether a woman had inad-
equate intake. The relatively poorer reliability seen in
these tests is likely due to the fact that women reported
lower choline intake at each visit. This trend may reflect
interview fatigue, as has been reported in several other
studies [46]; after familiarization with the procedure,
women may have chosen fewer cards from the QFFQ
card sorting as a result of fatigue and/or a conscious at-
tempt to shorten the interview. Indeed, reliability was
better from visits 1-2 than 2-3, but this difference may
also reflect the longer time period between interviews (8
weeks for visits 2-3 vs. 4 weeks for visits 1-2). An actual
reduction in food and thus choline intake towards the
end of the pregnancy must, however, also be considered.
The mean energy intake per day decreased somewhat
from each visit to the next (2294 kcal/day at visit 1, 2280
kcal/day at visit 2, 2194 kcal/day visit 3). As repeated ad-
ministration of the QFFQ did not significantly improve
validity the Choline-QFFQ screener could be used as a
single-visit screener.
This study had limitations common to other longitu-
dinal studies of nutrition. 24-hr dietary recall interviews
can yield inaccurate estimates of usual intake due to
recall errors. However, we have previously reported that
intraclass correlations and within-subject coefficients of
variation for dietary nutrient intakes in this cohort, in-
cluding choline, were similar to those of NHANES and
other peer-reviewed epidemiologic studies in the U.S.
[23], indicating that random error in this study did not
exceed levels generally accepted in the nutritional
epidemiology community. Furthermore, we found that
energy intake predicted gestational weight gain, further
supporting the validity of the 24-hr recall data. Where
possible, the method of triads, in which two dietary
assessment methods and a biochemical marker of
nutritional status for a given nutrient are compared, is
recommended for validation of FFQs [46]. We did not
employ this method because free choline and other
choline metabolites are tightly regulated and relatively
unresponsive to dietary changes, as homeostatic mecha-
nisms, such as estrogen-induced endogenous choline
production by the PEMT enzyme during pregnancy act
to keep plasma choline values in the normal range; lack
of correlation between diet and biochemical values is
thus common, particularly in cohorts without high rates
of severe choline deficiency [47, 48]. Differences between
true and estimated levels of maternal alcohol consumption
are likely small, given the validity of the interviewing
techniques demonstrated in this community in relation to
Carter et al. Nutrition Journal          (2018) 17:108 Page 10 of 13
meconium levels of fatty acid ethyl ester metabolites
of alcohol [49], infant and child behavior [7, 35, 50],
somatic growth [51], and brain structure [52–54] and
function [55].
Conclusions
To our knowledge, this is the first quantitative choline
food frequency screening questionnaire to be developed
and validated for use in both heavy and non-drinking
pregnant women and the first to be used in the Cape
Coloured community in South Africa. Given the high
prevalence of inadequate choline intake in this and other
communities worldwide and the growing evidence that
maternal choline supplementation may benefit infant
neurodevelopment and can mitigate adverse effects of
prenatal alcohol exposure, this tool may be useful for
both research and for future clinical outreach programs
aimed at identifying pregnant women at risk for choline
deficiency. The Choline-QFFQ development and valid-
ation methodology we employed can be used in other
communities as well, which may be of significant public
health utility given the widespread public health burdens
of dietary choline inadequacy and maternal alcohol con-
sumption during pregnancy. Our findings demonstrating
validity of the QFFQ for use in this highly disadvantaged,
poorly educated population supports its potential utility
for use in a broad range of social contexts.
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